Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile-Reference-Cited by-同舟云学术

Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

Published:2019-06-17 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Zhao Qingnan,Hu Jiemiao,Mitra Abhisek,Cutrera Jeffry,Zhang Wendong,Zhang Zhongting,Yan Jun,Xia Xueqing,Mahadeo Kris Michael,Livingston John Andrew,Gorlick Richard,Li Shulin^ORCID

Funder

Foundation for the National Institutes of Health

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0631-z.pdf

Reference49 articles.

1. Serrels A, Lund T, Serrels B, Byron A, McPherson RC, von Kriegsheim A, et al. Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity. Cell. 2015;163(1):160–73.

2. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–99.

3. Scott MC, Temiz NA, Sarver AE, LaRue RS, Rathe SK, Varshney J, et al. Comparative transcriptome analysis quantifies immune cell transcript levels, metastatic progression, and survival in osteosarcoma. Cancer Res. 2018;78(2):326–37.

4. Ali HR, Chlon L, Pharoah PD, Markowetz F, Caldas C. Patterns of immune infiltration in breast Cancer and their clinical implications: a gene-expression-based retrospective study. PLoS Med. 2016;13(12):e1002194.

5. Mattarollo SR, Loi S, Duret H, Ma Y, Zitvogel L, Smyth MJ. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res. 2011;71(14):4809–20.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials;Cancer Research Communications;2024-01-10

2. Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii;Frontiers in Immunology;2023-04-14

3. FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells;Nature Communications;2023-02-10

4. Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma;International Journal of Molecular Sciences;2023-01-02

5. IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines;Frontiers in Immunology;2022-09-20